MINNEAPOLIS, Minn. (KEYC) – The University of Minnesota says a federal change to classify medical marijuana as a schedule III drug instead of a schedule I drug could allow more detailed research on its impacts on public health and medicine.
Colin Planalp, a senior research fellow at the university’s Cannabis Research Center (CRC), says while it may be too soon to tell exactly what new research opportunities could be allowed under this change, it will most likely give researchers more options.
While the CRC doesn’t do medical research, it does conduct research on the public health effects of cannabis to help inform public policy and help Minnesotans make informed choices about consumption…